BPC-157 BPC-157 is a synthetic derived from a gastric juice protein, known for its regenerative properties
Q., Tournay A., Head E., Gillen D
Log in Amino-D-Tox Designs for Health $N/A (MSRP) Already have an account
In simple terms, abaloparatide may offer a more favorable ratio of bone building to bone breakdown
SURMOUNT-1 (tirzepatide, 72 weeks): Discontinuation due to AEs: 4.3% (5 mg), 7.1% (10 mg), 6.2% (15 mg) vs 2.6% placebo Key characteristics: GI events occur primarily during dose escalation The GIP component does not appear to add substantial GI burden beyond GLP-1 effects Pooled SURMOUNT-1 to -4 analysis showed treatment discontinuation due to GI AEs ranged from 1.0% to 10.5% Retatrutide# Retatrutide adds glucagon receptor agonism to GLP-1 and GIP, creating a triple agonist
As we discussed, estrogen enhances GLP-1 receptor sensitivity